1. FRI0309 A Phase I Pharmacokinetics TRIAL Comparing PF-05280586 (A Potential Biosimilar) and Rituximab in Subjects with Active Rheumatoid Arthritis with Active Disease in TNF Failures (Reflections B328-01). (10th June 2014) Authors: Yin, D.; Becker, J.-C.; Melia, L.A.; Li, R.; Gumbiner, B.; Thomas, D.; Spencer-Green, G.; Meng, X. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0190 A Phase I Trial Comparing PF-05280586 (A Potential Biosimilar) and Rituximab in Patients with Active Rheumatoid Arthritis. (9th June 2015) Authors: Jacobs, I.; Yin, D.; Melia, L.A.; Gumbiner, B.; Suster, M.; Thomas, D.; Meng, X. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗